Invitrocue, is a health tech startup specializing in personalized oncology testing and bioanalysis solutions. The company leverages cutting-edge 3D cell-based in vitro technologies to offer patient-specific cancer tests, enabling more precise and effective treatment strategies. By focusing on personalized medicine, Invitrocue aims to revolutionize cancer care by tailoring treatments to individual patient profiles. The startup is at the forefront of biotechnology innovation, contributing to advances in oncology and transforming the way cancer is diagnosed and treated. Their solutions are designed to enhance treatment outcomes and improve patient care in the rapidly evolving field of personalized oncology.

Year: 2021

Industry: Health Tech

Key Trends: Personalized medicine, oncology, biotechnology innovation